THIS MONTH HIGHLIGHTS


logo

Duke-NUS commercializes discovery for healthy brain development in babies and children

A discovery made at Duke-NUS Medical School (Duke-NUS) has been licensed to a newly launched Singapore-based company, Babynostics Pte Ltd.

logo

Role of nebivolol in the control and management of central aortic blood pressure in hypertensive patients

Measurement of blood pressure (BP) using a brachial cuff sphygmomanometer is universally accepted for the diagnosis of hypertension and prediction of cardiovascular diseases.


logo

100% Online Clinical Trial Platform

ObvioHealth commercializes two suites of software solutions to help healthcare industry players substantiate health claims as well as achieve better visibility on their healthcare professional network.


logo

Fighting Antibiotic Associated Diarrhea

A high quality probiotic product containing high concentration of Lactobacillus acidophilus and L. casei demonstrated to prevent Clostridium difficile infection and diarrhea during antibiotic treatment. The trial coordinated by SPRIM was published in the American Journal of Gastroenterology. A video

logo

Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome

Docosahexanoic acid (DHA) is the most abundant omega-3 fatty acid in brain, and, although it is considered essential, deficiency has not been linked to disease.